AAAAAA
Results: 1-25/49
Authors:
Johnston, S
Dowsett, M
Citation: S. Johnston et M. Dowsett, Special issue: Signal transduction inhibition - from concept to clinic - Foreword, ENDOCR-R CA, 8(3), 2001, pp. 149-150
Authors:
Dowsett, M
Citation: M. Dowsett, Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer, ENDOCR-R CA, 8(3), 2001, pp. 191-195
Authors:
Geisler, J
Detre, S
Berntsen, H
Ottestad, L
Lindtjorn, B
Dowsett, M
Lonning, PE
Citation: J. Geisler et al., Influence of neoadjuvant anastrozole (Arimidex) on intratumoral estrogen levels and proliferation markers in patients with locally advanced breast cancer, CLIN CANC R, 7(5), 2001, pp. 1230-1236
Authors:
Kelland, LR
Smith, V
Valenti, M
Patterson, L
Clarke, PA
Detre, S
End, D
Howes, AJ
Dowsett, M
Workman, P
Johnston, SRD
Citation: Lr. Kelland et al., Preclinical antitumor activity and pharmacodynamic studies with the farnesylprotein transferase inhibitor R115777 in human breast cancer, CLIN CANC R, 7(11), 2001, pp. 3544-3550
Authors:
Dowsett, M
Bundred, NJ
Decensi, A
Sainsbury, RC
Lu, YL
Hills, MJ
Cohen, FJ
Veronesi, P
O'Brien, MER
Scott, T
Muchmore, DB
Citation: M. Dowsett et al., Effect of raloxifene on breast cancer cell Ki67 and apoptosis: A double-blind, placebo-controlled, randomized clinical trial in postmenopausal patients, CANC EPID B, 10(9), 2001, pp. 961-966
Authors:
Harper-Wynne, C
Dowsett, M
Citation: C. Harper-wynne et M. Dowsett, Recent advances in the clinical application of aromatase inhibitors, J STEROID B, 76(1-5), 2001, pp. 179-186
Authors:
Parton, M
Dowsett, M
Smith, I
Citation: M. Parton et al., Studies of apoptosis in breast cancer, BR MED J, 322(7301), 2001, pp. 1528-1532
Authors:
Dowsett, M
Harper-Wynne, C
Boeddinghaus, I
Salter, J
Hills, M
Dixon, M
Ebbs, S
Gui, G
Sacks, N
Smith, I
Citation: M. Dowsett et al., HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer, CANCER RES, 61(23), 2001, pp. 8452-8458
Authors:
Robertson, JF
Nicholson, RI
Bundred, NJ
Anderson, E
Rayter, Z
Dowsett, M
Fox, JN
Gee, JMW
Webster, A
Wakeling, AE
Morris, C
Dixon, M
Citation: Jf. Robertson et al., Comparison of the short-term biological effects of 7 alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17 beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer, CANCER RES, 61(18), 2001, pp. 6739-6746
Authors:
Baum, M
Dowsett, M
Coibion, M
Bianco, AR
Cuzick, J
George, WD
Gray, J
Howell, A
Houghton, J
Williams, N
Sloane, J
Tobias, J
Buzdar, A
Anderson, MD
Jackson, I
Sahmoud, T
Gallagher, J
Webster, A
Gangji, D
Petrakova, K
Konopasek, B
Mares, P
Vodvarka, P
Alcazar, A
Campos, O
Maxwell, A",Goedhals,"Hacking, D
Landers, G
Smith, L
Vorobiof, DA
Werner, ID
Blamey, R
Coleman, R
Grieve, RJ
Hickish, T
Howell, A
Nicholls, JC
Nicholson, S
Raymond, S
Salman, A
Blum, J
Clark, R
Lyss, A
Miletello, G
Sternberg, J
Forbes, J
Coibion, M
Nabholtz, JM
Guastalla, JP
Distler, W
Klijn, JGM
Nagykalnai, T
Nicolucci, A
Bianco, AR
Constenla, M
Nylen, U
Howell, A
Sainsbury, R
Mansel, RE
Goerge, D
Buzdar, AU
Locker, GY
Gallagher, J
Jackson, I
Sahmoud, T
Houghton, J
Williams, N
Nicolucci, A
Pollard, S
Stroner, P
Buyse, M
Margolese, R
Northover, JMA
Citation: M. Baum et al., Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women: a sub-protocol of the 'Arimidex (TM) and Tamoxifen Alone or in Combination' (ATAC) trial, BR J CANC, 85(3), 2001, pp. 317-324
Authors:
Dowsett, M
Citation: M. Dowsett, Aromatase inhibition: The outcome of 20 years of drug development, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 3-15
Authors:
Johnston, SRD
Smith, IE
Dowsett, M
Citation: Srd. Johnston et al., Place of aromatase inhibitors in the endocrine therapy of breast cancer, AROMATASE INHIBITION AND BREAST CANCER, 2001, pp. 29-49
Authors:
Dowsett, M
Citation: M. Dowsett, New hurdles for translational research, BREAST CA R, 2(4), 2000, pp. 241-243
Authors:
Dowsett, M
Dixon, JM
Horgan, K
Salter, J
Hills, M
Harvey, E
Citation: M. Dowsett et al., Antiproliferative effects of idoxifene in a placebo-controlled trial in primary human breast cancer, CLIN CANC R, 6(6), 2000, pp. 2260-2267
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashley, SE
Makris, A
Gregory, RK
Osborne, CK
Dowsett, M
Citation: J. Chang et al., Prediction of clinical outcome from primary tamosifen by expression of biologic markers in breast cancer patients, CLIN CANC R, 6(2), 2000, pp. 616-621
Authors:
Dowsett, M
Cooke, T
Ellis, I
Gullick, WJ
Gusterson, B
Mallon, E
Walker, R
Citation: M. Dowsett et al., Assessment of HER2 status in breast cancer: why, when and how?, EUR J CANC, 36(2), 2000, pp. 170-176
Authors:
Dowsett, M
Citation: M. Dowsett, Use of risk determinants for different breast cancer prevention strategies, EUR J CANC, 36(10), 2000, pp. 1283-1287
Authors:
Chang, J
Powles, TJ
Allred, DC
Ashley, SE
Clark, GM
Dowsett, M
Citation: J. Chang et al., Predictors of response to chemotherapy - In Reply, J CL ONCOL, 18(7), 2000, pp. 1601-1602
Authors:
Dowsett, M
Donaldson, K
Tsuboi, M
Wong, J
Yates, R
Citation: M. Dowsett et al., Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women, CANC CHEMOT, 46(1), 2000, pp. 35-39
Authors:
Zabaglo, L
Ormerod, MG
Dowsett, M
Citation: L. Zabaglo et al., Measurement of markers for breast cancer in a model system using laser scanning cytometry, CYTOMETRY, 41(3), 2000, pp. 166-171
Authors:
Gregory, RK
Powles, TJ
Salter, J
Chang, JC
Ashley, S
Dowsett, M
Citation: Rk. Gregory et al., Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy, BREAST CANC, 59(2), 2000, pp. 171-175
Authors:
Ellis, IO
Dowsett, M
Bartlett, J
Walker, R
Cooke, T
Gullick, W
Gusterson, B
Mallon, E
Lee, PB
Citation: Io. Ellis et al., Recommendations for HER2 testing in the UK, J CLIN PATH, 53(12), 2000, pp. 890-892
Authors:
van der Flier, S
Chan, CMW
Brinkman, A
Smid, M
Johnston, SRD
Dorssers, LCJ
Dowsett, M
Citation: S. Van Der Flier et al., BCAR1/p130CAS expression in untreated and acquired tamoxifen-resistant human breast carcinomas, INT J CANC, 89(5), 2000, pp. 465-468
Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma
Authors:
Chang, J
Ormerod, M
Powles, TJ
Allred, DC
Ashley, SE
Dowsett, M
Citation: J. Chang et al., Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma, CANCER, 89(11), 2000, pp. 2145-2152
Authors:
Leake, R
Anderson, L
Dowsett, M
Iles, R
Nicholson, R
Robertson, J
Walker, R
Citation: R. Leake et al., Can biological markers improve the management of breast cancer patients?, BR J CANC, 82(10), 2000, pp. 1625-1626